central nervous system depressants

Preferred Label : central nervous system depressants;

MeSH definition : A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents).;

MeSH synonym : depressants, cns; cns depressants;

MeSH annotation : GEN or unspecified; prefer specific groups or specific drugs; consider also CENTRAL NERVOUS SYSTEM /drug eff or BRAIN /drug eff; DF: CNS DEPRESS; GEN or unspecified; prefer specific groups or specific drugs; consider also CENTRAL NERVOUS SYSTEM /drug eff or BRAIN /drug eff; general or unspecified; prefer specifics;

Wikipedia link : https://en.wikipedia.org/wiki/Cns depressants;

Is substance : O;

action pharmacologique : O;

Détails

Origin ID

D002492;

UMLS CUI

C0007681;

ATC code(s)
- antispasmodics in combination with psycholeptics [ATC Code]
- bucetin, combinations with psycholeptics [ATC Code]
- carbenoxolone, combinations with psycholeptics [ATC Code]
- chlormezanone, combinations with psycholeptics [ATC Code]
- clidinium and psycholeptics [ATC Code]
- dipyrocetyl, combinations with psycholeptics [ATC Code]
- emepronium and psycholeptics [ATC Code]
- ethanol [ATC Code]
- homatropine methylbromide and psycholeptics [ATC Code]
- hyoscyamine and psycholeptics [ATC Code]
- methocarbamol, combinations with psycholeptics [ATC Code]
- oxyphencyclimine and psycholeptics [ATC Code]
- paracetamol, combinations with psycholeptics [ATC Code]
- pipenzolate and psycholeptics [ATC Code]
- propantheline and psycholeptics [ATC Code]
- synthetic anticholinergic agents in combination with psycholeptics [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- CNS DEPRESSION NOS [WHO-ART Included Term]
- CNS depression [MedDRA LLT]
- Central depressant (substance) [SNOMED CT concept]
- Central nervous system depressants [ICHI extension code]
- Central nervous system depressants barbiturates [ICHI extension code]
- Central nervous system depression (disorder) [SNOMED CT concept]
- Depressant central nervous system (anesthetic) [ICD-11 Extension code]
- Depression central nervous system [MedDRA LLT]
- central depressant, nos [SNOMED Notion]
- psycholeptics [ATC Code]
Currated CISMeF NLP mapping
- Central nervous system depressants [ICD-11 Extension code]
Record concept(s)
- central nervous system depressants [MeSH concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- Amisulpride [MeSH Descriptor]
- Aripiprazole [MeSH Descriptor]
- Clobazam [MeSH Descriptor]
- Gabapentin [MeSH Descriptor]
- Lamotrigine [MeSH Descriptor]
- Lurasidone Hydrochloride [MeSH Descriptor]
- Mirtazapine [MeSH Descriptor]
- Olanzapine [MeSH Descriptor]
- Paliperidone Palmitate [MeSH Descriptor]
- Pregabalin [MeSH Descriptor]
- Quetiapine Fumarate [MeSH Descriptor]
- Vortioxetine [MeSH Descriptor]
- acepromazine [MeSH Descriptor]
- benperidol [MeSH Descriptor]
- bromazepam [MeSH Descriptor]
- buspirone [MeSH Descriptor]
- butaclamol [MeSH Descriptor]
- carbamazepine [MeSH Descriptor]
- chlormezanone [MeSH Descriptor]
- chlorpromazine [MeSH Descriptor]
- chlorprothixene [MeSH Descriptor]
- clopenthixol [MeSH Descriptor]
- clorazepate dipotassium [MeSH Descriptor]
- clozapine [MeSH Descriptor]
- droperidol [MeSH Descriptor]
- estazolam [MeSH Descriptor]
- etazolate [MeSH Descriptor]
- ethanol [MeSH Descriptor]
- flunitrazepam [MeSH Descriptor]
- flupenthixol [MeSH Descriptor]
- fluphenazine [MeSH Descriptor]
- fluspirilene [MeSH Descriptor]
- fluvoxamine [MeSH Descriptor]
- haloperidol [MeSH Descriptor]
- lithium carbonate [MeSH Descriptor]
- lithium chloride [MeSH Descriptor]
- lithium compounds [MeSH Descriptor]
- loxapine [MeSH Descriptor]
- melatonin [MeSH Descriptor]
- mesoridazine [MeSH Descriptor]
- methiothepin [MeSH Descriptor]
- methotrimeprazine [MeSH Descriptor]
- molindone [MeSH Descriptor]
- nordazepam [MeSH Descriptor]
- oxprenolol [MeSH Descriptor]
- penfluridol [MeSH Descriptor]
- perazine [MeSH Descriptor]
- perphenazine [MeSH Descriptor]
- pimozide [MeSH Descriptor]
- prazepam [MeSH Descriptor]
- prochlorperazine [MeSH Descriptor]
- promazine [MeSH Descriptor]
- raclopride [MeSH Descriptor]
- remoxipride [MeSH Descriptor]
- reserpine [MeSH Descriptor]
- risperidone [MeSH Descriptor]
- ritanserin [MeSH Descriptor]
- spiperone [MeSH Descriptor]
- sulpiride [MeSH Descriptor]
- thioridazine [MeSH Descriptor]
- thiothixene [MeSH Descriptor]
- tiapride hydrochloride [MeSH Descriptor]
- tranylcypromine [MeSH Descriptor]
- trazodone [MeSH Descriptor]
- triazolam [MeSH Descriptor]
- trifluoperazine [MeSH Descriptor]
- trifluperidol [MeSH Descriptor]
- triflupromazine [MeSH Descriptor]
- valproic acid [MeSH Descriptor]
- zolazepam [MeSH Descriptor]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients